Your browser doesn't support javascript.
loading
VEGF-C prophylaxis favors lymphatic drainage and modulates neuroinflammation in a stroke model.
Boisserand, Ligia Simoes Braga; Geraldo, Luiz Henrique; Bouchart, Jean; El Kamouh, Marie-Renee; Lee, Seyoung; Sanganahalli, Basavaraju G; Spajer, Myriam; Zhang, Shenqi; Lee, Sungwoon; Parent, Maxime; Xue, Yuechuan; Skarica, Mario; Yin, Xiangyun; Guegan, Justine; Boyé, Kevin; Saceanu Leser, Felipe; Jacob, Laurent; Poulet, Mathilde; Li, Mingfeng; Liu, Xiodan; Velazquez, Sofia E; Singhabahu, Ruchith; Robinson, Mark E; Askenase, Michael H; Osherov, Artem; Sestan, Nenad; Zhou, Jiangbing; Alitalo, Kari; Song, Eric; Eichmann, Anne; Sansing, Lauren H; Benveniste, Helene; Hyder, Fahmeed; Thomas, Jean-Leon.
Afiliação
  • Boisserand LSB; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.
  • Geraldo LH; Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT, USA.
  • Bouchart J; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.
  • El Kamouh MR; Paris Brain Institute, Université Pierre et Marie Curie Paris 06 UMRS1127, Sorbonne Université , Paris, France.
  • Lee S; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.
  • Sanganahalli BG; Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA.
  • Spajer M; Paris Brain Institute, Université Pierre et Marie Curie Paris 06 UMRS1127, Sorbonne Université , Paris, France.
  • Zhang S; Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
  • Lee S; Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA.
  • Parent M; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.
  • Xue Y; Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA.
  • Skarica M; Department of Anesthesiology, Yale School of Medicine, New Haven, CT, USA.
  • Yin X; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.
  • Guegan J; Department of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
  • Boyé K; Kavli Institute for Neuroscience, Yale School of Medicine , New Haven, CT, USA.
  • Saceanu Leser F; Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, USA.
  • Jacob L; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
  • Poulet M; Paris Brain Institute, Université Pierre et Marie Curie Paris 06 UMRS1127, Sorbonne Université , Paris, France.
  • Li M; Paris Cardiovascular Research Center, INSERM U970 , Paris, France.
  • Liu X; Paris Cardiovascular Research Center, INSERM U970 , Paris, France.
  • Velazquez SE; Glial Cell Biology Laboratory, Biomedical Sciences Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Singhabahu R; Paris Cardiovascular Research Center, INSERM U970 , Paris, France.
  • Robinson ME; Paris Cardiovascular Research Center, INSERM U970 , Paris, France.
  • Askenase MH; Department of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
  • Osherov A; Kavli Institute for Neuroscience, Yale School of Medicine , New Haven, CT, USA.
  • Sestan N; Department of Anesthesiology, Yale School of Medicine, New Haven, CT, USA.
  • Zhou J; Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT, USA.
  • Alitalo K; Paris Brain Institute, Université Pierre et Marie Curie Paris 06 UMRS1127, Sorbonne Université , Paris, France.
  • Song E; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
  • Eichmann A; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
  • Sansing LH; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
  • Benveniste H; Department of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
  • Hyder F; Kavli Institute for Neuroscience, Yale School of Medicine , New Haven, CT, USA.
  • Thomas JL; Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
J Exp Med ; 221(4)2024 Apr 01.
Article em En | MEDLINE | ID: mdl-38442272
ABSTRACT
Meningeal lymphatic vessels (MLVs) promote tissue clearance and immune surveillance in the central nervous system (CNS). Vascular endothelial growth factor-C (VEGF-C) regulates MLV development and maintenance and has therapeutic potential for treating neurological disorders. Herein, we investigated the effects of VEGF-C overexpression on brain fluid drainage and ischemic stroke outcomes in mice. Intracerebrospinal administration of an adeno-associated virus expressing mouse full-length VEGF-C (AAV-mVEGF-C) increased CSF drainage to the deep cervical lymph nodes (dCLNs) by enhancing lymphatic growth and upregulated neuroprotective signaling pathways identified by single nuclei RNA sequencing of brain cells. In a mouse model of ischemic stroke, AAV-mVEGF-C pretreatment reduced stroke injury and ameliorated motor performances in the subacute stage, associated with mitigated microglia-mediated inflammation and increased BDNF signaling in brain cells. Neuroprotective effects of VEGF-C were lost upon cauterization of the dCLN afferent lymphatics and not mimicked by acute post-stroke VEGF-C injection. We conclude that VEGF-C prophylaxis promotes multiple vascular, immune, and neural responses that culminate in a protection against neurological damage in acute ischemic stroke.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / AVC Isquêmico Limite: Animals Idioma: En Revista: J Exp Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / AVC Isquêmico Limite: Animals Idioma: En Revista: J Exp Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos